FindTrial
Sign In

A study for adipose-derived mesenchymal stem cells as adjuvant therapy in the treatment of severe hemorrhagic cystitis after transplantation of allogeneic hematopoietic stem cell

A study for adipose-derived mesenchymal stem cells as adjuvant therapy in the treatment of severe hemorrhagic cystitis after transplantation of allogeneic hematopoietic stem cell

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800020431
Enrollment
Unknown
Registered
2018-12-29
Start date
2019-01-20
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemorrhagic cystitis

Interventions

Case series:Adipose-derived mesenchymal stem cells

Sponsors

The First Affiliated Hospital of Xinjiang Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Patients with severe hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation; 2. Agreed to join the study.

Exclusion criteria

Exclusion criteria: Patients with multiple organ failure.

Design outcomes

Primary

MeasureTime frame
Immunologic function;—

Countries

China

Contacts

Public ContactHailong Yuan

The First Affiliated Hospital of Xinjiang Medical University

1074913015@qq.com+86 13999961228

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026